# DESCRIPTION

## INTRODUCTION

- motivate immunotherapy

## SUMMARY OF THE INVENTION

- summarize invention aspects

## DETAILED DESCRIPTION OF THE INVENTION

- define cancer and subject
- introduce extracellular vesicles (EVs) and their role in cancer
- describe systemic suppression of the immune system by EVs
- define therapeutically effective amounts of administered agents
- introduce inhibition of suppressive EVs as a strategy for cancer treatment
- describe various suppressive EV inhibitors and their mechanisms of action
- provide examples of small molecules, peptides, and constructs that inhibit suppressive EVs
- describe methods of inhibiting systemic suppression of the immune system and treating cancer using suppressive EV inhibitors
- discuss delivery of suppressive EV inhibitors to tumor cells
- describe delivery agent and suppressive EV inhibitor
- motivate standalone treatment and co-administration with immunotherapy agents
- describe co-administration with various immunotherapy agents
- describe co-administration with cancer fighting agents other than immunotherapy agents
- describe administration methods and formulations
- motivate engineered cancer cells for immunization against tumors
- describe method of treating cancer using engineered cancer cells
- describe engineered cancer cells with reduced suppressive EV activity or production
- describe gene disruption methods
- outline protein modification techniques
- summarize engineered cancer cell modifications
- describe vaccine composition and administration
- outline therapeutic methods for cancer treatment
- describe prognostic methods for assessing treatment response
- outline suppressive EV quantification methods
- describe fusion protein tools for EV visualization and quantification
- define fusion proteins
- describe applications of fusion proteins
- motivate suppressive EVs as immunosuppressive agents
- describe therapeutic immunosuppressive EVs
- outline production of EVs
- describe administration of therapeutic immunosuppressive EVs
- summarize pharmaceutical composition

## EXAMPLES

### Example 1

- inhibit suppressive exosomes
- describe exosome biogenesis
- demonstrate exosome tracking and quantification

### Example 2

- introduce PD-L1 and its role in cancer
- describe exosomes and their biogenesis
- show that cancer cells secrete PD-L1 in exosomes
- investigate differential secretion of PD-L1 between cancer cell lines
- demonstrate that PD-L1 is specifically secreted within exosomes
- show that exosomal PD-L1 suppresses T cell activation
- demonstrate that exosomal PD-L1 promotes tumor progression
- show that exosomal PD-L1 suppresses priming of T cells in the draining lymph node
- demonstrate that exposure to tumor cells lacking exosomes or PD-L1 results in a robust memory response
- motivate exosomal PD-L1 in tumor progression
- evaluate effect of exosomal PD-L1 on tumor growth
- investigate role of exosomal PD-L1 in immune suppression
- demonstrate exosomal PD-L1 rescue of immune suppression and tumor growth
- discuss implications of exosomal PD-L1 in cancer immunotherapy
- describe methods for CRISPR-Cas9-mediated gene disruption and nanoparticle tracking analysis
- outline tumor cell injection and treatment protocols

